Christian Behrenbruch, CEO of Telix Pharmaceuticals TLX, has filed 2 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $996.7K. The latest trade was on 04/29.

CB

CB

Christian Behrenbruch

MD & Group CEO

Company

Telix Pharmaceuticals TLX

First filing

26/05/06

Trades

2 trades

Buys / sales

2 / 0

12-month net buying

$996.7K

Last trade

04/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Telix PharmaceuticalsTLX	Open-market buy	04/28–04/29	05/06	67,935 sh2 trades	$14.67avg.	$996,738.45	+0.3%